Prelude Therapeutics Incorporated
NASDAQ:PRLDBiotechnology
Healthcare
$3.32 -3.22%
-$0.14 today
- Market cap
- $192.16M
- Beta
- 1.01
- P/E (TTM)
- -4.5
- EPS (TTM)
- -$0.94
52W Low $0.75High $5.54
Volume 0.42M
Average 0.38M
Price history
Prelude Therapeutics Incorporated SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+97.62%
Period high
$6.63
Period low
$1.35
Latest
$3.32
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Sep 10, 2026 | Sep 10, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| SC 13G | Jul 8, 2026 | Jul 8, 2026 | |
| 4 | Jun 10, 2026 | Jun 10, 2026 | |
| 4 | Jun 10, 2026 | Jun 10, 2026 | |
| 4 | Jun 10, 2026 | Jun 10, 2026 | |
| 4 | Jun 10, 2026 | Jun 10, 2026 | |
| 4 | Jun 10, 2026 | Jun 10, 2026 | |
| 8-K | Jun 10, 2026 | Jun 10, 2026 | |
| 4 | Jun 10, 2026 | Jun 10, 2026 | |
| 8-K | May 12, 2026 | May 12, 2026 | |
| 10-Q | May 12, 2026 | May 12, 2026 | |
| 4 | May 4, 2026 | May 4, 2026 | |
| DEFA14A | Apr 29, 2026 | Apr 29, 2026 |
Competitors
Who does Prelude Therapeutics Incorporated compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about PRLD's filings, answered from its disclosures.
What is the latest PRLD filing?
The latest filing shown is 8-K dated Sep 10, 2026.
How many recent filings does PRLD have?
Intrinsic Alpha currently shows 20 recent filings for PRLD.
Continue the stock analysis
Jump to another research area for this company.